MC-16

N/A

Report date: 2024/03/22 16:54:53
NMEFirst In Class

Base Information

Drug NameMC-16
Drug Alias NameMC-16MC16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial oxidative phosphorylation modulators
TargetsUpdating
Therapy Area/IndicationsGeographic AtrophyGlaucomaRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitoChem Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMitoChem Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyGlaucomaRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A